{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:35:27Z","timestamp":1792640127773,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Sichuan Provincial Department of Science and Technology","doi-asserted-by":"crossref","award":["2023NSFSC0619"],"award-info":[{"award-number":["2023NSFSC0619"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82174431"],"award-info":[{"award-number":["No.82174431"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-05088-2","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:07:10Z","timestamp":1760522830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and security of oral Chinese patent medicine combined with antibiotics in the treatment of pelvic inflammatory disease: a Bayesian network meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Mao-Ya","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Zhi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Li","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Bin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"RR-03","key":"5088_CR1","first-page":"1","volume":"64","author":"KA Workowski","year":"2015","unstructured":"Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1\u2013137 Erratum in: MMWR Recomm Rep. 2015 Aug 28;64(33):924. PMID: 26042815; PMCID: PMC5885289.","journal-title":"MMWR Recomm Rep."},{"key":"5088_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15585\/mmwr.mm6603a3","volume":"66","author":"K Kreisel","year":"2017","unstructured":"Kreisel K, Torrone E, Bernstein K, Hong J, Gorwitz R. Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age\u2014United States, 2013\u20132014. MMWR Morb Mortal Wkly Rep. 2017;66:80\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"5088_CR3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1186\/s12889-023-16663-y","volume":"23","author":"D He","year":"2023","unstructured":"He D, Wang T, Ren W. Global burden of pelvic inflammatory disease and ectopic pregnancy from 1990 to 2019. BMC Public Health. 2023;23(1):1894. https:\/\/doi.org\/10.1186\/s12889-023-16663-y.","journal-title":"BMC Public Health"},{"issue":"1","key":"5088_CR4","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1017\/S0950268816002065","volume":"145","author":"MJ Price","year":"2017","unstructured":"Price MJ, Ades AE, Welton NJ, et al. Pelvic inflammatory disease and salpingitis: incidence of primary and repeat episodes in England. Epidemiol Infect. 2017;145(1):208\u201315. https:\/\/doi.org\/10.1017\/S0950268816002065.","journal-title":"Epidemiol Infect"},{"issue":"7","key":"5088_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/OLQ.0000000000000996","volume":"46","author":"GE Anyalechi","year":"2019","unstructured":"Anyalechi GE, Hong J, Kreisel K, et al. Self-reported infertility and associated pelvic inflammatory disease among women of reproductive age-national health and nutrition examination survey, United States, 2013\u20132016. Sex Transm Dis. 2019;46(7):446\u201351.","journal-title":"Sex Transm Dis"},{"issue":"8","key":"5088_CR6","doi-asserted-by":"publisher","first-page":"e0219351","DOI":"10.1371\/journal.pone.0219351","volume":"14","author":"CC Huang","year":"2019","unstructured":"Huang CC, Huang CC, Lin SY, et al. Association of pelvic inflammatory disease (PID)with ectopic pregnancy and preterm labor in Taiwan: a nationwide population-based retrospective cohort study. PLoS One. 2019;14(8):e0219351.","journal-title":"PLoS One"},{"issue":"11","key":"5088_CR7","doi-asserted-by":"publisher","first-page":"e747","DOI":"10.1016\/j.jogc.2018.08.015","volume":"40","author":"JF Jarrell","year":"2018","unstructured":"Jarrell JF, Vilos GA, Allaire C, et al. No. 164-consensus guidelines for the management of chronic pelvic pain. J Obstet Gynaecol Can. 2018;40(11):e747\u201387.","journal-title":"J Obstet Gynaecol Can."},{"key":"5088_CR8","unstructured":"Centers for Disease Control and Prevention; Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006;55(RR-11):1\u201394. Erratum in: MMWR Recomm Rep. 2006;55(36):997. PMID: 16888612."},{"key":"5088_CR9","unstructured":"Workowski,K.A., Berman,S., & Centers for Disease Control and Prevention (CDC)(2010). Sexuallytransmitted diseases treatment guidelines, 2010. MMWR. Recommendations and reports : Morbidity and mortalityweekly report. Recommendations and reports, 59(RR-12). 1-110."},{"issue":"4","key":"5088_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. M M WR Recomm Rep. 70(4).1-187.","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"5088_CR11","first-page":"433","volume":"54","author":"Infectious Diseases Collaborative Group","year":"2019","unstructured":"Infectious Diseases Collaborative Group, Obstetrics and Gynecology Branch of Chinese Medical Association. Code for the diagnosis and treatment of pelvic inflammatory diseases (2019 revised edition). Chin J Obstet Gynecol. 2019;54(7):433\u20137.","journal-title":"Chin J Obstet Gynecol"},{"issue":"16","key":"5088_CR12","first-page":"2024","volume":"41","author":"DA Zhao","year":"2020","unstructured":"Zhao DA, Zhao XY, Zhou L, Fang XY, Yang HY, Gao T. Analysis of pathogenic bacteria and drug resistance of female pelvic inflammatory disease in Jinchang city. Int J Lab Med. 2020;41(16):2024\u20137.","journal-title":"Int J Lab Med"},{"issue":"15","key":"5088_CR13","first-page":"146","volume":"9","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Zhang Y, Cui FX, Ren CN. Pathogenic bacteria and drug susceptibility in women with acute pelvic infection. China Med Pharm. 2019;9(15):146-148,215.","journal-title":"China Med Pharm"},{"key":"5088_CR14","first-page":"141","volume":"02","author":"MW Yang","year":"2006","unstructured":"Yang MW, Lu FE, Xu LJ, Liu YJ, Chen R. Preliminary observation of 20 antipyretic and detoxifying traditional Chinese medicines on in vitro bacteriostatic effects of methicillin-resistant Staphylococcus aureus. China Pharmacist. 2006;02:141\u20132.","journal-title":"China Pharmacist."},{"issue":"02","key":"5088_CR15","first-page":"97","volume":"38","author":"J Zeng","year":"2021","unstructured":"Zeng J, Xu JJ, Xiong R, Li M. Extraction and bacteriostatic effect of flavonoids of Ophioglossa albiflora. J Chongqing Normal Univ (Natural Science). 2021;38(02):97\u2013104.","journal-title":"J Chongqing Normal Univ (Natural Science)"},{"issue":"11","key":"5088_CR16","first-page":"26","volume":"33","author":"N Zhao","year":"2020","unstructured":"Zhao N, Fang CX, Wang LL, Nan WQ. Discussion on analgesic, anti-inflammatory and in vitro bacteriostatic effects of Beicheng soy herb. Western J Trad Chi Med. 2020;33(11):26\u20139.","journal-title":"Western J Trad Chi Med"},{"issue":"01","key":"5088_CR17","first-page":"49","volume":"41","author":"JX Li","year":"2019","unstructured":"Li JX, Yang FQ, Wang HX, Zhang LM. Study on the bacteriostatic effect of Ningxia and Qinghai on 8 strains. J Ningxia Med Univ. 2019;41(01):49\u201352.","journal-title":"J Ningxia Med Univ"},{"key":"5088_CR18","doi-asserted-by":"publisher","unstructured":"Tang X, Wu ZF, Sun P, Yi B, Liu XH, Liu ZF, Song MX, Yang M. Application prospect of new technology and new equipment in production of Chinese patent medicine. Zhongguo Zhong Yao Za Zhi. 2019;44(21):4560\u20134565. Chinese. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20190804.304. PMID: 31872648.","DOI":"10.19540\/j.cnki.cjcmm.20190804.304"},{"issue":"12","key":"5088_CR19","doi-asserted-by":"publisher","first-page":"e5211","DOI":"10.1002\/bmc.5211","volume":"35","author":"Y Gou","year":"2021","unstructured":"Gou Y, Geng Z, Zhong L, et al. A new strategy for quality evaluation and control of Chinese patent medicine based on chiral isomer ratio analysis: with Yuanhuzhitong tablet as an example. Biomed Chromatogr. 2021;35(12):e5211. https:\/\/doi.org\/10.1002\/bmc.5211.","journal-title":"Biomed Chromatogr"},{"key":"5088_CR20","doi-asserted-by":"publisher","first-page":"574562","DOI":"10.3389\/fphar.2020.574562","volume":"11","author":"N Zhang","year":"2020","unstructured":"Zhang N, Shi N, Li S, et al. A retrospective study on the use of Chinese patent medicine in 24 medical institutions for COVID-19 in China. Front Pharmacol. 2020;11:574562. https:\/\/doi.org\/10.3389\/fphar.2020.574562.","journal-title":"Front Pharmacol."},{"issue":"04","key":"5088_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.19538\/j.fk2019040120","volume":"35","author":"L Huang","year":"2019","unstructured":"Huang L, Wei SB, Luo M, Zhang S, Li MY. Efficacy and security of Kangfuyan capsules combined with antimicrobials in pelvic inflammatory disease: a meta-analysis. Chin J Pract Gynecol Obstet. 2019;35(04):455\u201361. https:\/\/doi.org\/10.19538\/j.fk2019040120.","journal-title":"Chin J Pract Gynecol Obstet"},{"key":"5088_CR22","unstructured":"Expert consensus on the clinical application of Kangfuyan capsules in the treatment of gynecological inflammatory diseases. Chin J Integr Tradit Western Med. 2022;42(04):412\u2013418."},{"issue":"16","key":"5088_CR23","first-page":"3090","volume":"41","author":"L Wang","year":"2016","unstructured":"Wang L, Xu R, Zhang SH, Ma SY, Xu YN. A meta-analysis of the efficacy of Fuke Qianjin tablets (capsules) in combination with antibiotics in the treatment of endometritis. China J Chin Mater Med. 2016;41(16):3090\u20135.","journal-title":"China J Chin Mater Med"},{"key":"5088_CR24","unstructured":"Zhang HJ. A literature study of clinical practice guidelines for the treatment of pelvic inflammatory disease with traditional Chinese medicine alone\/in combination with antibiotics[D]. Chengdu Univ Tradit Chin Med. 2019."},{"key":"5088_CR25","doi-asserted-by":"crossref","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Welch VA. Cochrane handbook for systematic reviews of interventions. Cochrane Handbook for Systematic Reviews of Interventions; 2019.","DOI":"10.1002\/9781119536604"},{"key":"5088_CR26","doi-asserted-by":"publisher","first-page":"m3907","DOI":"10.1136\/bmj.m3907","volume":"371","author":"R Brignardello-Petersen","year":"2020","unstructured":"Brignardello-Petersen R, Izcovich A, Rochwerg B, Florez ID, Hazlewood G, Alhazanni W, et al. Grade approach to drawing conclusions from a network meta-analysis using a partially contextualised framework. BMJ (Clinical research ed). 2020;371:m3907. https:\/\/doi.org\/10.1136\/bmj.m3907.","journal-title":"BMJ (Clinical research ed)"},{"issue":"4","key":"5088_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, Oxman AD, Guyatt GH. GRADE guidelines: 3. rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"5088_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1.introduction-grade evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"5088_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/1469-0691.12494","volume":"20","author":"WG Melsen","year":"2014","unstructured":"Melsen WG, Bootsma MC, Rovers MM, Bonten MJ. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 2014;20(2):123\u20139. https:\/\/doi.org\/10.1111\/1469-0691.12494.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"5088_CR30","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80\u201397. https:\/\/doi.org\/10.1002\/jrsm.1037.","journal-title":"Res Synth Methods"},{"key":"5088_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11739-016-1583-7","volume":"12","author":"B Rouse","year":"2017","unstructured":"Rouse B, Chaimani A, Li T. Network meta-analysis: an introduction for clinicians. Intern Emerg Med. 2017;12:103\u201311.","journal-title":"Intern Emerg Med"},{"key":"5088_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","volume":"33","author":"S Dias","year":"2012","unstructured":"Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2. Med Decis Making. 2012;33:607\u201317. https:\/\/doi.org\/10.1177\/0272989X12458724.","journal-title":"Med Decis Making"},{"issue":"04","key":"5088_CR33","first-page":"103","volume":"15","author":"CQ Yu","year":"2017","unstructured":"Yu CQ. Analysis of the effect of moxifloxacin combined with Fuke Qianjin tablets in the treatment of acute pelvic inflammatory disease. Contemp Med Symp. 2017;15(04):103\u20134.","journal-title":"Contemp Med Symp"},{"issue":"06","key":"5088_CR34","first-page":"992","volume":"22","author":"FY Yu","year":"2013","unstructured":"Yu FY, Zhou LJ. Clinical observation of Fuke Qianjin Tablets combined with antibiotics in the treatment of acute pelvic inflammatory disease. J Emerg Tradit Chin Med. 2013;22(06):992\u20133.","journal-title":"J Emerg Tradit Chin Med"},{"issue":"07","key":"5088_CR35","doi-asserted-by":"publisher","first-page":"148","DOI":"10.16281\/j.cnki.jocml.2019.07.129","volume":"6","author":"LH Liu","year":"2019","unstructured":"Liu LH. Clinical observation of 58 cases of adnexitis treated with Fuke Qianjin capsules combined with antibiotics. Electron J Clin Med Lit. 2019;6(07):148. https:\/\/doi.org\/10.16281\/j.cnki.jocml.2019.07.129.","journal-title":"Electron J Clin Med Lit."},{"issue":"27","key":"5088_CR36","first-page":"156","volume":"12","author":"XK Bao","year":"2010","unstructured":"Bao XK. Analysis of 126 cases of Fuke Qianjin capsules combined with antibiotics in the treatment of acute pelvic inflammatory disease. Chin Community Doct. 2010;12(27):156.","journal-title":"Chin Community Doct"},{"issue":"22","key":"5088_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.13214\/j.cnki.cj0tadm.2015.22.055","volume":"23","author":"L Sun","year":"2015","unstructured":"Sun L, Gao Y. Clinical efficacy of Fuke Qianjin Tablets combined with antibiotics in the treatment of acute pelvic inflammatory disease. Chin J Trauma Disabil Med. 2015;23(22):75\u20136. https:\/\/doi.org\/10.13214\/j.cnki.cj0tadm.2015.22.055.","journal-title":"Chin J Trauma Disabil Med"},{"issue":"13","key":"5088_CR38","first-page":"105","volume":"14","author":"YH Zhang","year":"2016","unstructured":"Zhang YH. Evaluation of the effect of the combination of gatifloxacin, metronidazole and Fuke Qianjin Tablets in the treatment of acute pelvic inflammatory disease. Contemp Med Symp. 2016;14(13):105\u20136.","journal-title":"Contemp Med Symp"},{"issue":"02","key":"5088_CR39","first-page":"108","volume":"28","author":"XY Fang","year":"2016","unstructured":"Fang XY. Clinical efficacy of Fuke Qianjin Tablets combined with antibiotics in the treatment of adnexitis. Strait Pharmaceut J. 2016;28(02):108\u20139.","journal-title":"Strait Pharmaceut J"},{"issue":"02","key":"5088_CR40","first-page":"182","volume":"26","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Li J, Yin HY. Effect of fuke qianjin tablets on serum CRP, IL-6 and TNF-\u03b1 concentrations in patients with acute pelvic inflammatory disease. J Radioimmunol. 2013;26(02):182\u20133.","journal-title":"J Radioimmunol"},{"key":"5088_CR41","first-page":"82","volume":"25","author":"R Li","year":"2021","unstructured":"Li R. Observation of the efficacy of Fuke Qianjin capsules combined with antibiotics in the treatment of pelvic inflammatory diseases. Chin Baby. 2021;25:82.","journal-title":"Chin Baby"},{"issue":"10","key":"5088_CR42","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.13192\/j.issn.1000-1719.2013.10.013","volume":"40","author":"WR Lin","year":"2013","unstructured":"Lin WR, Wang W. Clinical study on 86 cases of acute pelvic inflammation treated by Chinese Proprietary Fuke Qianjin Tablet. Liaoning J Tradit Chin Med. 2013;40(10):2065\u20137. https:\/\/doi.org\/10.13192\/j.issn.1000-1719.2013.10.013.","journal-title":"Liaoning J Tradit Chin Med"},{"key":"5088_CR43","first-page":"61","volume":"1","author":"JQ Shen","year":"2018","unstructured":"Shen JQ. Application and efficacy analysis of Fuke Qianjin capsules plus antibiotics in the treatment of endometritis. Med Diet Health. 2018;1:61\u201377.","journal-title":"Med Diet Health"},{"issue":"62","key":"5088_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3969\/j.issn.1671-3141.2021.62.096","volume":"21","author":"AN Wen","year":"2021","unstructured":"Wen AN, Lu GF, Dong LL. Effect of Fuke Qianjin tablets combined with Levofloxacin on treatment, security and inflammatory factors in patients with pelvic inflammatory disease. World\u2019s Latest Med Inform Digest. 2021;21(62):235\u20136. https:\/\/doi.org\/10.3969\/j.issn.1671-3141.2021.62.096.","journal-title":"World's Latest Med Inform Digest"},{"issue":"16","key":"5088_CR45","first-page":"116","volume":"23","author":"ZY Wang","year":"2014","unstructured":"Wang ZY. Fuke qianjin tablets adjuvant treatment of acute pelvic inflammatory disease in 38 cases. China Pharmaceut. 2014;23(16):116.","journal-title":"China Pharmaceut"},{"issue":"33","key":"5088_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.15887\/j.cnki.13-1389\/r.2018.33.011","volume":"11","author":"CX Wang","year":"2018","unstructured":"Wang CX, Shan TY, Yan HX, Su ZY, Li W, Han WH, et al. Clinical efficacy and security of antibacterial drugs combined with Fuke Qianjin Tablets in the treatment of endometritis. Chin J Clin Ration Drug Use. 2018;11(33):21\u20132. https:\/\/doi.org\/10.15887\/j.cnki.13-1389\/r.2018.33.011.","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"06","key":"5088_CR47","first-page":"971","volume":"20","author":"Y Wang","year":"2011","unstructured":"Wang Y. Fuke Qianjin capsules combined with antibiotics for acute pelvic inflammatory disease were treated in 62 cases. J Emerg Tradit Chin Med. 2011;20(06):971\u20132.","journal-title":"J Emerg Tradit Chin Med"},{"key":"5088_CR48","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3969\/j.issn.1006-1959.2015.33.396","volume":"33","author":"YX Tian","year":"2015","unstructured":"Tian YX. Clinical efficacy of antibiotic therapy with adnexitis in 92 cases. J Med Inform. 2015;33:261\u20132. https:\/\/doi.org\/10.3969\/j.issn.1006-1959.2015.33.396.","journal-title":"J Med Inform"},{"key":"5088_CR49","first-page":"187","volume":"04","author":"D Luo","year":"2018","unstructured":"Luo D. Application effect of antibiotics combined with Fuke Qianjin capsules in the treatment of pelvic inflammatory diseases. Home Med. 2018;04:187.","journal-title":"Home Med"},{"key":"5088_CR50","first-page":"31","volume":"5","author":"XH Fan","year":"2018","unstructured":"Fan XH. Analysis of the effectiveness of treatment with Fuke Qianjin Tablets combined with antibiotic regimens for acute pelvic inflammatory disease. Med Diet Health. 2018;5:31\u20132.","journal-title":"Med Diet Health"},{"key":"5088_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3969\/j.issn.1006-6845.2017.42.044","volume":"42","author":"J Zhao","year":"2017","unstructured":"Zhao J, Huang XS, Zhang RF. To explore the clinical efficacy of Fuke Qianjin Tablets combined with penicillin in the treatment of acute pelvic inflammatory disease. Health Guide. 2017;42:50. https:\/\/doi.org\/10.3969\/j.issn.1006-6845.2017.42.044.","journal-title":"Health Guide"},{"issue":"07","key":"5088_CR52","first-page":"91","volume":"13","author":"XS Xin","year":"2016","unstructured":"Xin XS. To study the clinical effect of cefuroxime, tinidazole combined with Fuke Qianjin capsules in the treatment of pelvic inflammatory diseases. J North Pharm. 2016;13(07):91\u20132.","journal-title":"J North Pharm"},{"issue":"11","key":"5088_CR53","first-page":"2666","volume":"12","author":"FB Jin","year":"2017","unstructured":"Jin FB, Li YB, Ren B, Liu T, Yang J. To explore the clinical effect of integrated traditional Chinese and Western medicine in the treatment of endometritis. World Chin Med. 2017;12(11):2666\u20138+2673.","journal-title":"World Chin Med"},{"key":"5088_CR54","first-page":"89+122","volume":"06","author":"L Chen","year":"2019","unstructured":"Chen L. Application of Fuke Qianjin capsules in the treatment of pelvic inflammatory diseases. Women\u2019s Health Res. 2019;06:89+122.","journal-title":"Women's Health Res"},{"issue":"30","key":"5088_CR55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3969\/j.issn.2095-8439.2018.30.014","volume":"5","author":"XH Chen","year":"2018","unstructured":"Chen XH. Observation of the efficacy of Fuke Qianjin capsules combined with antibiotics in the treatment of adnexitis. Diet Health. 2018;5(30):13\u20134. https:\/\/doi.org\/10.3969\/j.issn.2095-8439.2018.30.014.","journal-title":"Diet Health"},{"key":"5088_CR56","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3969\/j.issn.1005-0019.2022.10.037","volume":"10","author":"J Chen","year":"2022","unstructured":"Chen J. Clinical therapeutic effect of penicillin combined with Fuke Qianjin Tablets in the treatment of acute pelvic inflammatory disease. Health Horiz. 2022;10:61\u20133. https:\/\/doi.org\/10.3969\/j.issn.1005-0019.2022.10.037.","journal-title":"Health Horiz"},{"key":"5088_CR57","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3969\/j.issn.1005-0019.2019.05.091","volume":"5","author":"LR Lei","year":"2019","unstructured":"Lei LR. Analysis of the effect of Fuke Qianjin capsules combined with antibiotics in the treatment of pelvic inflammatory diseases. Health Horiz. 2019;5:61. https:\/\/doi.org\/10.3969\/j.issn.1005-0019.2019.05.091.","journal-title":"Health Horiz"},{"issue":"07","key":"5088_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.15887\/j.cnki.13-1389\/r.2012.07.120","volume":"5","author":"S Rao","year":"2012","unstructured":"Rao S, Yan YM. Observation of the efficacy of Fuke Qianjin Tablets combined with antibiotics in the treatment of acute pelvic inflammatory disease. Chin J Clin Ration Drug Use. 2012;5(07):62\u20133. https:\/\/doi.org\/10.15887\/j.cnki.13-1389\/r.2012.07.120.","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"35","key":"5088_CR59","first-page":"40","volume":"24","author":"YX Ren","year":"2018","unstructured":"Ren YX. Clinical efficacy and security evaluation of Kanfuyan capsule and antibiotic combination regimen in the treatment of pelvic inflammatory disease. Contemp Med. 2018;24(35):40\u20132.","journal-title":"Contemp Med"},{"issue":"2","key":"5088_CR60","first-page":"117","volume":"9","author":"YY Wu","year":"2020","unstructured":"Wu YY. Clinical study of pelvic inflammatory disease treated with Kanfuyan Capsule combined with antibiotics. J Electrocardiogram (Electronic Edition). 2020;9(2):117\u20138.","journal-title":"J Electrocardiogram (Electronic Edition)."},{"key":"5088_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3969\/j.issn.2095-6851.2018.19.180","volume":"19","author":"T Zhang","year":"2018","unstructured":"Zhang T. Clinical efficacy analysis of cefoxitin sodium combined with with Kanfuyan Capsule in the treatment of acute pelvic inflammatory disease and its effect on IL-6 and CRP. Special Health. 2018;19:114. https:\/\/doi.org\/10.3969\/j.issn.2095-6851.2018.19.180.","journal-title":"Special Health"},{"issue":"07","key":"5088_CR62","doi-asserted-by":"publisher","first-page":"746","DOI":"10.19538\/j.fk2017070122","volume":"33","author":"YK Cao","year":"2017","unstructured":"Cao YK, Zhu CY, Li YY, Chen LM, Diao WJ, Xie F, et al. A randomized controlled study of Kanfuyan Capsule in combination with antibiotics for pelvic inflammatory disease. Chin J Pract Gynecol Obstet. 2017;33(07):746\u201350. https:\/\/doi.org\/10.19538\/j.fk2017070122.","journal-title":"Chin J Pract Gynecol Obstet"},{"issue":"03","key":"5088_CR63","doi-asserted-by":"publisher","first-page":"603","DOI":"10.14035\/j.cnki.hljyy.2019.03.044","volume":"32","author":"SQ Li","year":"2019","unstructured":"Li SQ. Analysis and study of clinical effectiveness of Kanfuyan Capsule in the treatment of pelvic inflammatory diseases. Heilongjiang Med J. 2019;32(03):603\u20135. https:\/\/doi.org\/10.14035\/j.cnki.hljyy.2019.03.044.","journal-title":"Heilongjiang Med J"},{"issue":"01","key":"5088_CR64","first-page":"99","volume":"27","author":"YM Yang","year":"2021","unstructured":"Yang YM, Wang SS, Song JJ, Gong LZ. A controlled clinical study of cefixime and ornidazole combined with Kanfuyan capsule in the treatment of pelvic inflammatory diseases. J Clin Psychosom Dis. 2021;27(01):99\u2013101.","journal-title":"J Clin Psychosom Dis"},{"issue":"12","key":"5088_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.13764\/j.cnki.lcsy.2020.12.011","volume":"21","author":"XH Xiong","year":"2020","unstructured":"Xiong XH. The effect of Kanfuyan Capsule combined with levofloxacin and metronidazole in the treatment of pelvic inflammatory disease. Pract Clin Med. 2020;21(12):37\u20139. https:\/\/doi.org\/10.13764\/j.cnki.lcsy.2020.12.011.","journal-title":"Pract Clin Med"},{"issue":"02","key":"5088_CR66","first-page":"24","volume":"28","author":"L Dong","year":"2016","unstructured":"Dong L. Efficacy of Kanfuyan capsule combined with levofloxacin and metronidazole in the treatment of patients with pelvic inflammatory disease and artificial abortion. China Civil Kang Med. 2016;28(02):24\u20135.","journal-title":"China Civil Kang Med"},{"issue":"6","key":"5088_CR67","first-page":"3","volume":"39","author":"Y Gao","year":"2021","unstructured":"Gao Y. Efficacy analysis of Kanfuyan capsules and antibiotics in patients with outpatient pelvic inflammatory disease. Chin Health Care. 2021;39(6):3\u20135.","journal-title":"Chin Health Care"},{"key":"5088_CR68","first-page":"13","volume":"40","author":"LX Wang","year":"2019","unstructured":"Wang LX. Clinical study of pelvic inflammatory disease treated with Kanfuyan Capsule combined with antibiotics. Health Guide. 2019;40:13.","journal-title":"Health Guide"},{"issue":"2","key":"5088_CR69","first-page":"201","volume":"25","author":"HC Yan","year":"2018","unstructured":"Yan HC, Yang JP. Clinical efficacy of cefoxitin sodium combined with Kanfuyan Capsule in the treatment of pelvic inflammatory disease and its effect on inflammatory factors. Chin J Prim Med Pharm. 2018;25(2):201\u20134.","journal-title":"Chin J Prim Med Pharm"},{"key":"5088_CR70","first-page":"165","volume":"9","author":"YD Cao","year":"2019","unstructured":"Cao YD. Clinical efficacy and effect on quality of life of Kanfuyan Capsule combined with levofloxacin metronidazole in patients with pelvic inflammatory disease. Home Med. 2019;9:165.","journal-title":"Home Med"},{"issue":"29","key":"5088_CR71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.16040\/j.cnki.cn15-1101.2013.29.016","volume":"32","author":"XR Liu","year":"2013","unstructured":"Liu XR. Clinical exploration of 58 cases of Huahong Tablet in the treatment of acute pelvic inflammatory disease. Inner Mongolia J Tradit Chin Med. 2013;32(29):4\u20135. https:\/\/doi.org\/10.16040\/j.cnki.cn15-1101.2013.29.016.","journal-title":"Inner Mongolia J Tradit Chin Med"},{"issue":"14","key":"5088_CR72","first-page":"116","volume":"21","author":"JX Lou","year":"2015","unstructured":"Lou JX. Effect of levofloxacin in combination with Huahong tablet in the treatment of acute pelvic inflammatory disease. Contemp Med. 2015;21(14):116\u20137.","journal-title":"Contemp Med"},{"issue":"13","key":"5088_CR73","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.4103\/0366-6999.211896","volume":"32","author":"WL Xu","year":"2017","unstructured":"Xu WL. 32 cases of acute pelvic inflammation treated by huahong capsule combined with antibiotics. Guangming J Chin Med. 2017;32(13):1945\u20136.","journal-title":"Guangming J Chin Med"},{"key":"5088_CR74","first-page":"27","volume":"2","author":"XY Zhang","year":"2015","unstructured":"Zhang XY. Observation on the effect of treating pelvic inflammation with Jingangteng Capsule. Contemp Med Symp. 2015;2:27\u20138.","journal-title":"Contemp Med Symp"},{"issue":"36","key":"5088_CR75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.15887\/j.cnki.13-1389\/r.2021.36.013","volume":"14","author":"HL Chen","year":"2021","unstructured":"Chen HL. Clinical study of Jingangteng Capsule combined with levofloxacin in the treatment of pelvic inflammatory diseases. Chin J Clin Ration Drug Use. 2021;14(36):42\u20134. https:\/\/doi.org\/10.15887\/j.cnki.13-1389\/r.2021.36.013.","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"29","key":"5088_CR76","first-page":"4099","volume":"27","author":"XR Ren","year":"2016","unstructured":"Ren XR, Zhu HF, Shen HJ, Wang J. Clinical observation of Fuyankang combined with azithromycin in the treatment of pelvic inflammatory disease. China Pharm. 2016;27(29):4099\u2013101.","journal-title":"China Pharm"},{"key":"5088_CR77","unstructured":"Liu XY, Ming LJ. Effects of Fuyankang combined with azithromycin on inflammatory indexes and uterine blood flow in patients with mycoplasma infection with pelvic inflammatory disease. World Healthy Living. 2021(10):129."},{"issue":"21","key":"5088_CR78","first-page":"3955","volume":"28","author":"P Xin","year":"2019","unstructured":"Xin P. Effects of Fuyankang combined with azithromycin on inflammatory indexes and uterine blood flow in patients with mycoplasma infection with pelvic inflammatory disease. Henan Med Res. 2019;28(21):3955\u20136.","journal-title":"Henan Med Res"},{"issue":"18","key":"5088_CR79","first-page":"111","volume":"9","author":"ZD Ji","year":"2018","unstructured":"Ji ZD, Li HF, Zhang XF. Clinical observation of Fuyankang combined with azithromycin in the treatment of pelvic inflammatory disease. China Health Stand Manag. 2018;9(18):111\u20133.","journal-title":"China Health Stand Manag"},{"issue":"03","key":"5088_CR80","first-page":"53","volume":"7","author":"QY Wu","year":"2018","unstructured":"Wu QY. Clinical observation of Fuyankang combined with azithromycin in the treatment of pelvic inflammatory disease. Disaster Med Rescue (Electronic Edition). 2018;7(03):53\u20134.","journal-title":"Disaster Med Rescue (Electronic Edition)"},{"issue":"5","key":"5088_CR81","doi-asserted-by":"publisher","first-page":"196","DOI":"10.13457\/j.cnki.jncm.2019.05.059","volume":"51","author":"SS Zhou","year":"2019","unstructured":"Zhou SS. The efficacy of Fuyanxiao Capsule combined with conventional western medicine in the treatment of acute pelvic inflammatory disease and its effect on serum inflammatory factor levels. New Chin Med. 2019;51(5):196\u20138. https:\/\/doi.org\/10.13457\/j.cnki.jncm.2019.05.059.","journal-title":"New Chin Med"},{"issue":"11","key":"5088_CR82","doi-asserted-by":"publisher","first-page":"113","DOI":"10.13457\/j.cnki.jncm.2016.11.050","volume":"48","author":"YY Shi","year":"2016","unstructured":"Shi YY, Yu YY. Clinical observation of Fuyanxiao Capsule combined with western medicine in the treatment of acute pelvic inflammatory disease. New Chin Med. 2016;48(11):113\u20134. https:\/\/doi.org\/10.13457\/j.cnki.jncm.2016.11.050.","journal-title":"New Chin Med"},{"issue":"12","key":"5088_CR83","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3969\/j.issn.1000-338X.2021.12.003","volume":"52","author":"JH Zhu","year":"2021","unstructured":"Zhu JH. Fuyanxiao Capsule combined with western medicine for the treatment of acute pelvic inflammatory disease in 73 cases. Fujian J Tradit Chin Med. 2021;52(12):7\u20139. https:\/\/doi.org\/10.3969\/j.issn.1000-338X.2021.12.003.","journal-title":"Fujian J Tradit Chin Med"},{"issue":"11","key":"5088_CR84","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.3969\/j.issn.1673-7202.2017.11.013","volume":"12","author":"R Tong","year":"2017","unstructured":"Tong R, Liu YQ, Xin YX. Clinical efficacy of Fuyanxiao Capsule combined with western medicine in the treatment of acute pelvic inflammatory disease and its effect on blood rheology. World Chin Med. 2017;12(11):2619\u201322. https:\/\/doi.org\/10.3969\/j.issn.1673-7202.2017.11.013.","journal-title":"World Chin Med"},{"issue":"2","key":"5088_CR85","first-page":"359","volume":"44","author":"ZH Yuan","year":"2022","unstructured":"Yuan ZH. Clinical observation of Fuyanxiao capsule in auxiliary treatment of acute pelvic inflammation. Sichuan J Physiol Sci. 2022;44(2):359-360,363.","journal-title":"Sichuan J Physiol Sci"},{"issue":"1","key":"5088_CR86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.13359\/j.cnki.gzxbtcm.2018.01.004","volume":"35","author":"LQ Zhang","year":"2018","unstructured":"Zhang LQ, Qi QH, Zhou LS. Clinical observation of antibiotic combined with Fule Tablets intensive consolidation regimen in the treatment of pelvic inflammatory disease. J Guangzhou Univ Tradit Chin Med. 2018;35(1):19\u201323. https:\/\/doi.org\/10.13359\/j.cnki.gzxbtcm.2018.01.004.","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"issue":"13","key":"5088_CR87","doi-asserted-by":"publisher","first-page":"130","DOI":"10.13638\/j.issn.1671-4040.2021.13.064","volume":"21","author":"ZF Zhang","year":"2021","unstructured":"Zhang ZF. Clinical efficacy of Fule Tablets combined with cefixime and tinidazole in the treatment of patients with pelvic inflammatory disease. Pract Clin J Integr Tradit Chin Western Med. 2021;21(13):130\u20131. https:\/\/doi.org\/10.13638\/j.issn.1671-4040.2021.13.064.","journal-title":"Pract Clin J Integr Tradit Chin Western Med"},{"issue":"26","key":"5088_CR88","doi-asserted-by":"publisher","first-page":"86","DOI":"10.19347\/j.cnki.2096-1413.202026034","volume":"5","author":"HR Tuo","year":"2020","unstructured":"Tuo HR. Clinical effect of Fule Tablets combined with antibacterial therapy in the treatment of pelvic inflammatory diseases. Clin Res Pract. 2020;5(26):86\u20138. https:\/\/doi.org\/10.19347\/j.cnki.2096-1413.202026034.","journal-title":"Clin Res Pract"},{"issue":"12","key":"5088_CR89","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.7501\/j.issn.1674-5515.2019.12.035","volume":"34","author":"LL Xiong","year":"2019","unstructured":"Xiong LL, Tian XY, Cai XL, Yin Q. Clinical study on Fule grain combined with clindamycin phosphate in treating endometritis. Drugs Clin. 2019;34(12):3660\u20133. https:\/\/doi.org\/10.7501\/j.issn.1674-5515.2019.12.035.","journal-title":"Drugs Clin"},{"issue":"12","key":"5088_CR90","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.19540\/j.cnki.cjcmm.20190305.003","volume":"44","author":"XL Feng","year":"2019","unstructured":"Feng XL, Jiang S, Chen J. Effect of Fuyanshu Capsule combined with antibiotic therapy on inflammatory factors in patients with pelvic inflammatory disease. Chin J Chin Mater Med. 2019;44(12):2637\u201343. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20190305.003.","journal-title":"Chin J Chin Mater Med"},{"issue":"04","key":"5088_CR91","doi-asserted-by":"publisher","first-page":"383","DOI":"10.13390\/j.issn.1672-1861.2021.04.013","volume":"22","author":"Y Lu","year":"2021","unstructured":"Lu Y, Lou JY, Feng XL. Efficacy and security of Fuyanshu capsule combined with antibacterial drugs in the treatment of pelvic inflammatory disease: a randomized controlled clinical study. Chin J Clin Obstet Gynecol. 2021;22(04):383\u20135. https:\/\/doi.org\/10.13390\/j.issn.1672-1861.2021.04.013.","journal-title":"Chin J Clin Obstet Gynecol"},{"issue":"21","key":"5088_CR92","first-page":"56","volume":"28","author":"SS Chen","year":"2019","unstructured":"Chen SS, Huang XM. Clinical study on fuyanshu capsule combined with azithromycin in the treatment of mycoplasma infected pelvic inflammation. China Pharmaceut. 2019;28(21):56\u20138.","journal-title":"China Pharmaceut"},{"issue":"10","key":"5088_CR93","first-page":"1760","volume":"22","author":"SX Du","year":"2013","unstructured":"Du SX, Tian ZF, Lin SY. Clinical observation of Fuyan Kangfu Capsule combined with antibiotics in the treatment of acute pelvic inflammatory disease. J Emerg Tradit Chin Med. 2013;22(10):1760\u20131.","journal-title":"J Emerg Tradit Chin Med"},{"key":"5088_CR94","first-page":"43","volume":"18","author":"LH Yang","year":"2020","unstructured":"Yang LH, Ma HM, Kang J, Wang LH, Yu HM. Analysis of clinical research protocols of Jinying capsules for the treatment of pelvic inflammatory diseases. Health Manag. 2020;18:43.","journal-title":"Health Manag"},{"issue":"3","key":"5088_CR95","doi-asserted-by":"publisher","first-page":"432","DOI":"10.19852\/j.cnki.jtcm.2020.03.011","volume":"40","author":"Y Yang","year":"2020","unstructured":"Yang Y, Lu Y, Zhou D, Pei F, Li Q, Chen S, et al. Effectiveness of Jinying capsule on pelvic inflammatory disease in patients with symptom pattern of damp and heat accumulation: a double-blinded, multicenter, randomized, placebo-controlled clinical trial. J Tradit Chin Med. 2020;40(3):432\u20139. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2020.03.011. PMID: 32506857.","journal-title":"J Tradit Chin Med."},{"issue":"28","key":"5088_CR96","first-page":"99","volume":"13","author":"CY Wang","year":"2021","unstructured":"Wang CY. Effect of Penyanjing oral solution combined with antibiotics on hemorheology and inflammatory factors in patients with pelvic inflammatory disease. Clin J Chin Med. 2021;13(28):99\u2013101.","journal-title":"Clin J Chin Med"},{"issue":"07","key":"5088_CR97","doi-asserted-by":"publisher","first-page":"161","DOI":"10.14163\/j.cnki.11-5547\/r.2021.07.070","volume":"16","author":"M Long","year":"2021","unstructured":"Long M, Zhang LP. Clinical efficacy of Penyanjing capsule combined with moxifloxacin in the treatment of acute pelvic inflammatory disease. China Pract Med. 2021;16(07):161\u20133. https:\/\/doi.org\/10.14163\/j.cnki.11-5547\/r.2021.07.070.","journal-title":"China Pract Med"},{"key":"5088_CR98","unstructured":"Luo W, Yi JP. Clinical efficacy study of antimicrobial drugs combined with Fuke Qianjin capsule in pelvic inflammatory disease (PID). Chin Sci Technol J Database (Citation Edition) Med Health. 2024(12):025\u2013028."},{"key":"5088_CR99","unstructured":"Xie XM. Evaluation of the effect of cefuroxime and metronidazole combined with Fuke Qianjin capsule in the treatment of pelvic inflammatory diseases. Chin Sci Technol J Database (Citation Edition) Med Health. 2023(8):76\u201379."},{"issue":"21","key":"5088_CR100","first-page":"25","volume":"29","author":"L Guo","year":"2023","unstructured":"Guo L, Xu DJ, Xu XW. Clinical efficacy of Huang Hong capsule combined with antibiotics in the treatment of acute pelvic inflammatory disease. Contemp Med. 2023;29(21):25\u20138.","journal-title":"Contemp Med"},{"issue":"2","key":"5088_CR101","first-page":"162","volume":"38","author":"SL Wang","year":"2023","unstructured":"Wang SL, Zheng YL, Huang MY. Application of Huang Hong granules in female pelvic inflammatory disease. Sanit Urban Rural Enterprises China. 2023;38(2):162\u20135.","journal-title":"Sanit Urban Rural Enterprises China"},{"issue":"23","key":"5088_CR102","first-page":"153","volume":"55","author":"FX Zheng","year":"2023","unstructured":"Zheng FX, Ma YF, Liu GX. Clinical study of Jingangteng capsule combined with cefoxitin sodium injection in the treatment of pelvic inflammatory disease. New Chin Med. 2023;55(23):153\u20137.","journal-title":"New Chin Med"},{"issue":"4","key":"5088_CR103","first-page":"29","volume":"54","author":"YJ Li","year":"2023","unstructured":"Li YJ. Kangfuyan capsule combined with cefoperazone, sulbactam sodium and morpholinonirazole in the treatment of pelvic inflammatory diseases. Guangzhou Med. 2023;54(4):29\u201333.","journal-title":"Guangzhou Med"},{"issue":"11","key":"5088_CR104","first-page":"99","volume":"2","author":"JK Xue","year":"2023","unstructured":"Xue JK. The therapeutic effect of cefixime and ornidazole combined with Kangfuyan capsule on pelvic inflammatory disease. Women\u2019s Child Health Guide. 2023;2(11):99\u2013101.","journal-title":"Women's Child Health Guide"},{"issue":"9","key":"5088_CR105","first-page":"91","volume":"50","author":"ZQ Yao","year":"2023","unstructured":"Yao ZQ, Zhang XJ, Wang YH. Observation of the clinical efficacy of Penyanjing oral liquidin the treatment of pelvic inflammatory disease. Liaoning J Tradit Chin Med. 2023;50(9):91\u20134.","journal-title":"Liaoning J Tradit Chin Med"},{"issue":"01","key":"5088_CR106","first-page":"109","volume":"23","author":"XJ Yang","year":"2012","unstructured":"Yang XJ, Zhen YJ, Li N, Liang Y, Wang B. Antibacterial and antioxidative activities of Asian dandelion polysaccharides. Lishizhen Med Mater Res. 2012;23(01):109\u201310.","journal-title":"Lishizhen Med Mater Res"},{"issue":"03","key":"5088_CR107","first-page":"64","volume":"53","author":"JL Hou","year":"2017","unstructured":"Hou JL, Zhou XN, Feng SS, Zhao XH. Study on the anti-inflammatory effects of different extracts of dandelion. Chin J Vet Med. 2017;53(03):64\u20136.","journal-title":"Chin J Vet Med"},{"issue":"06","key":"5088_CR108","first-page":"806","volume":"40","author":"W Zhao","year":"2021","unstructured":"Zhao W, Hao MM, Sun P, Ruan JY, Wang T, Zhang Y. Research progress on pharmacological activity and stability of iridoids in Hedyotis diffusa. J Tianjin Univ Tradit Chin Med. 2021;40(06):806\u201310.","journal-title":"J Tianjin Univ Tradit Chin Med"},{"issue":"21","key":"5088_CR109","first-page":"5645","volume":"51","author":"XK Li","year":"2020","unstructured":"Li XK, Gu K, Liang MW, Zhang YT, Wang YM, Li YB. Research progress on chemical composition and pharmacological effects of coix kernel. Chin Tradit Herb Drugs. 2020;51(21):5645\u201357.","journal-title":"Chin Tradit Herb Drugs"},{"issue":"12","key":"5088_CR110","first-page":"1104","volume":"34","author":"L Yu","year":"2017","unstructured":"Yu L, Wang F, Guo Q, Liu KK, Zhang DC, Liang DL. Research progress on chemical composition and pharmacological activity of Ophioglossum albiflora. J Shenyang Pharm Univ. 2017;34(12):1104\u201314.","journal-title":"J Shenyang Pharm Univ"},{"issue":"06","key":"5088_CR111","first-page":"816","volume":"33","author":"SL Chen","year":"2017","unstructured":"Chen SL, Han L. Modern research progress on Vinifolia. J Guangdong Pharmaceut Univ. 2017;33(06):816\u201321.","journal-title":"J Guangdong Pharmaceut Univ"},{"issue":"10","key":"5088_CR112","first-page":"2204","volume":"32","author":"JH Li","year":"2017","unstructured":"Li JH, Yao F, Xiao YF, Shang CX, Mo F, Jin Z, et al. Pharmacodynamic study of anti-inflammatory and analgesic capsules of Kang gynecology. Matern Child Health Care China. 2017;32(10):2204\u20137.","journal-title":"Matern Child Health Care China."},{"issue":"12","key":"5088_CR113","first-page":"104","volume":"29","author":"JY Zhao","year":"2021","unstructured":"Zhao JY, Zhao R, He QZ. Effects of fuyanshu capsules combined with metronidazole on clinical efficacy, immune function, CRP and MCP-1 levels in patients with chronic pelvic inflammatory disease. Clin Res. 2021;29(12):104\u20137.","journal-title":"Clin Res"},{"issue":"11","key":"5088_CR114","first-page":"1320","volume":"40","author":"J Xu","year":"2020","unstructured":"Xu J, Xia BH, Deng J. Study on the immune activity of gynecology Qianjin capsule on spleen lymphocytes in mice. J Hunan Univ Tradit Chin Med. 2020;40(11):1320\u20136.","journal-title":"J Hunan Univ Tradit Chin Med"},{"issue":"11","key":"5088_CR115","first-page":"44","volume":"22","author":"QH Zhang","year":"2016","unstructured":"Zhang QH, Huang XH, Huang M, Sun XR, Guo XG. Experimental study on the analgesic and anti-inflammatory effect of Jinying capsules. Guiding J Tradit Chin Med Pharm. 2016;22(11):44\u20135+48.","journal-title":"Guiding J Tradit Chin Med Pharm"},{"issue":"14","key":"5088_CR116","first-page":"20","volume":"12","author":"M Huang","year":"2016","unstructured":"Huang M, Wang L, Huang XH. Effect of jinying capsules on endometrial inflammation and inflammatory adhesions in rat models of pelvic inflammatory disease. Asia-Pacific Tradit Med. 2016;12(14):20\u20133.","journal-title":"Asia-Pacific Tradit Med"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05088-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05088-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05088-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:07:02Z","timestamp":1760526422000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05088-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5088"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05088-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"26 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"374"}}